Regulation of muscle regulatory factors by DNA-binding, interacting proteins, and post-transcriptional modifications

Journal of Cellular Physiology

Volumn 185, Issue 2, 2000, Pages 155-173

  Puri, Pier Lorenzo ^a   Sartorelli, Vittorio ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA BINDING PROTEIN; HELIX LOOP HELIX PROTEIN; TRANSCRIPTION FACTOR;

CELL DIFFERENTIATION; DNA BINDING; GENE EXPRESSION; GENETIC TRANSCRIPTION; MUSCLE DEVELOPMENT; MYOBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REVIEW; RHABDOMYOSARCOMA; SIGNAL TRANSDUCTION; TISSUE SPECIFICITY;

ANIMAL; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; HUMAN; MUSCLES; MYOD PROTEIN; MYOGENIC REGULATORY FACTORS; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; RHABDOMYOSARCOMA;

EID: 0033804899     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-4652(200011)185:2<155::AID-JCP1>3.0.CO;2-Z     Document Type: Review

References (234)

1. Degradation of myogenic transcription factor MyoD by the ubiquitin pathway in vivo and in vitro: Regulation by specific DNA binding
2. Serum-induced inhibition of myogenesis is differentially relieved by retinoic acid and triiodothyronine in C2 murine muscle cells
3. Oncogenes and muscle differentiation: Multiple mechanisms of interference
4. Functional specificity of the two retinoic acid receptor RAR and RXR families in myogenesis
5. Twist and Notch negatively regulate adult muscle differentiation in Drosophila
6. Muscle LIM protein, a novel essential regulator of myogenesis, promotes myogenic differentiation
7. Muscle differentiation: More complexity to the network of myogenic regulators
8. The nuclear receptor corepressor N-CoR regulates differentiation: N-CoR directly interacts with MyoD
9. The orphan nuclear receptor, COUP-TF II, inhibits myogenesis by post-transcriptional regulation of MyoD function: COUP-TF II directly interacts with p300 and myoD
10. The role of E-proteins in B- and T-lymphocyte development
11. Id proteins control growth induction in mammalian cells
12. Twist: A myogenic switch in Drosophila
13. The protein Id: A negative regulator of helix-loop-helix DNA binding proteins
14. Positive control mutations in the MyoD basic region fail to show cooperative DNA binding and transcriptional activation in vitro
15. Functional antagonism between c-Jun and MyoD proteins: A direct physical association
16. Myogenic basic helix-loop-helix proteins and Sp1 interact as components of a multiprotein transcriptional complex required for activity of the human cardiac alpha-actin promoter
17. Repression of the Id2 (inhibitor of differentiation) gene promoter during exit from the cell cycle
18. Multiple roles for the MyoD basic region in transmission of transcriptional activation signals and interaction with MEF2
19. Binding of myc proteins to canonical and non-canonical DNA sequences
20. Sequence-specific DNA binding by the c-Myc protein
21. Differences and similarities in DNA-binding preferences of MyoD and E2A protein complexes revealed by binding site selection
22. TPA-induced differentiation of human rhabdomyosarcoma cells: Expression of the myogenic regulatory factors
23. Retinoblastoma protein recruits histone deacetylase to repress transcription
24. A novel site for ubiquitination: The N-terminal residue, and not internal lysines of MyoD, is essential for conjugation and degradation of the protein
25. Skeletal muscle development and the role of the myogenic regulatory factors
26. 3,5,3'-Triiodothyronine positively regulates both MyoD1 gene transcription and terminal differentiation in C2 myoblasts
27. Regulation of MyoD gene transcription and protein function by the transforming domains of the adenovirus E1A oncoprotein
28. A skeletal muscle-specific enhancer regulated by factors binding to E and CArG boxes is present in the promoter of the mouse myosin light-chain 1A gene
29. Critical role played by cyclin D3 in the MyoD-mediated arrest of cell cycle during myoblast differentiation
30. JunB is involved in the inhibition of myogenic differentiation by bone morphogenetic protein-2
31. I-mf, a novel myogenic repressor, interacts with members of the MyoD family
32. Twist is required in head mesenchyme for cranial neural tube morphogenesis
33. An Id-related helix-loop-helix protein encoded by a growth factor-inducible gene
34. Degradation of MyoD by the ubiquitin pathway: Regulation by specific DNA-binding and identification of a novel site for ubiquitination
35. Characterization of transcription factor E2F complexes during muscle and neuronal differentiation
36. MyoD induces growth arrest independent of differentiation in normal and transformed cells
37. The myogenic regulatory gene Mef2 is a direct target for transcriptional activation by Twist during Drosophila myogenesis
38. Twist is required for muscle template splitting during adult Drosophila myogenesis
39. Stress-activated protein kinase-2/p38 and a rapamycin-sensitive pathway are required for C2C12 myogenesis
40. Increase in p202 expression during skeletal muscle differentiation: Inhibition of MyoD protein expression and activity by p202
41. The MyoD DNA binding domain contains a recognition code for muscle-specific gene activation
42. Acquisition of myogenic specificity by replacement of three amino acid residues from MyoD into E12
43. CDK9 (PITALRE): A multifunctional cdc2-related kinase
44. An immediate early human gene encodes an Id-like helix-loop-helix protein and is regulated by protein kinase C activation in diverse cell types
45. Monoclonal antibodies to the myogenic regulatory protein MyoD1: Epitope mapping and diagnostic utility
46. Identification of a thyroid hormone response element in the mouse myogenin gene: Characterization of the thyroid hormone and retinoid X receptor heterodimeric binding site
47. The retinoic acid and retinoid X receptors are differentially expressed during myoblast differentiation
48. Expression of the helix-loop-helix genes Id-1 and NSCL-1 during cerebellar development
49. Molecular cloning and functional analysis of the adenovirus E1A-associated 300-kD protein (p300) reveals a protein with properties of a transcriptional adaptor
50. Interaction and functional collaboration of p300/CBP and bHLH proteins in muscle and B-cell differentiation
51. Crystal structure of transcription factor E47: E-box recognition by a basic region helix-loop-helix dimer
52. Retinoblastoma gene product Rb accumulates during myogenic differentiation and is deinduced by the expression of SV40 large T antigen
53. Transcription factors in hematopoiesis
54. Frequency and diversity of p53 mutations in childhood rhabdomyosarcoma
55. Recognition by Max of its cognate DNA through a dimeric b/HLH/Z domain
56. Amplification of MDM2 inhibits MyoD-mediated myogenesis
57. Hormones, growth factors, and myogenic differentiation
58. Retinoic acid receptors and muscle b-HLH proteins: Partners in retinoid-induced myogenesis
59. Expression of M-twist during postimplantation development of the mouse
60. Two domains of MyoD mediate transcriptional activation of genes in repressive chromatin: A mechanism for lineage determination in myogenesis
61. TPA-induced differentiation of human rhabdomyosarcoma cells involves dephosphorylation and nuclear accumulation of mutant P53
62. p300 and CBP: Partners for life and death
63. Collaborative interactions between MEF-2 and Sp1 in muscle-specifc gene regulation
64. Physical interaction between the mitogen-responsive serum response factor and myogenic basic-helix-loop-helix proteins
65. v-jun Oncogene prevents terminal differentiation and suppresses muscle-specific gene expression in ASV-17-infected muscle cells
66. Interaction of myogenic factors and the retinoblastoma protein mediates muscle cell commitment and differentiation
67. Inhibition of myogenesis by multiple cyclin-Cdk complexes. Coordinate regulation of myogenesis and cell cycle activity at the level of E2F
68. MyoD-induced expression of p21 inhibits cyclin-dependent kinase activity upon myocyte terminal differentiation
69. Identification of multiple proteins that interact with functional regions of the human cardiac alpha-actin promoter
70. Retinoic acid induces adult muscle cell differentiation mediated by the retinoic acid receptor-alpha
71. Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD
72. Regulation of histone acetyltransferases p300 and PCAF by the bHLH protein twist and adenoviral oncoprotein E1A
73. The basic domain of myogenic basic helix-loop-helix (bHLH) proteins is the novel target for direct inhibition by another bHLH protein, Twist
74. Activation of the transcription factor MEF2C by the MAP kinase p38 in inflammation
75. Differentially expressed fibroblast growth factors regulate skeletal muscle development through autocrine and paracrine mechanisms
76. The helix-loop-helix protein Id-1 and a retinoblastoma protein binding mutant of SV40 T antigen synergize to reactivate DNA synthesis in senescent human fibroblasts
77. Id-related genes encoding helix-loop-helix proteins are required for G1 progression and are repressed in senescent human fibroblasts
78. Fibroblast growth factor inhibits MRF4 activity independently of the phosphorylatlon status of a conserved threonine residue within the DNA-binding domain
79. Analysis of a Caenorhabditis elegans Twist homolog identifies conserved and divergent aspects of mesodermal patterning
80. Spontaneous and carcinogen-induced tumorigenesis in p53-deficient mice
81. Phosphorylation of a proline-directed kinase motif is responsible for structural changes in myogenin
82. Synergistic regulation of vertebrate muscle development by Dach2, Eya2, and Six1, homologs of genes required for Drosophila eye formation
83. M-twist is an inhibitor of muscle differentiation
84. TFIID (TBP) stabilizes the binding of MyoD to its DNA site at the promoter and MyoD facilitates the association of TFIIB with the preinitiation complex
85. A Xenopus mRNA related to Drosophila twist is expressed in response to induction in the mesoderm and the neural crest
86. Differences between MyoD DNA binding and activation site requirements revealed by functional random sequence selection
87. Intramolecular regulation of MyoD activation domain conformation and function
88. The helix-loop-helix protein Id-2 enhances cell proliferation and binds to the retinoblastoma protein
89. HLH proteins, fly neurogenesis, and vertebrate myogenesis
90. Overexpression of Id protein inhibits the muscle differentiation program: In vivo association of Id with E2A proteins
91. An essential role of phosphatidylinositol 3-kinase in myogenic differentiation
92. Casein kinase II increases the transcriptional activities of MRF4 and MyoD independently of their direct phosphorylation
93. Helix-loop-helix factors in growth and differentiation of the vertebrate nervous system
94. Expression and activity of the retinoblastoma protein (pRB)-family proteins, p107 and p130, during L6 myoblast differentiation
95. Inhibition of protein phosphatases blocks myogenesis by first altering MyoD binding activity
96. The muscle regulatory factors MyoD and myf-5 undergo distinct cell cycle-specific expression in muscle cells
97. cdk1- and cdk2-mediated phosphorylation of MyoD Ser200 in growing C2 myoblasts: Role in modulating MyoD half-life and myogenic activity
98. Elevated cyclins and cyclin-dependent kinase activity in the rhabdomyosarcoma cell line RD
99. Muscle LIM protein promotes myogenesis by enhancing the activity of MyoD
100. The intracellular domain of mouse Notch: A constitutively activated repressor of myogenesis directed at the basic helix-loop-helix region of MyoD
101. Establishment of distinct MyoD, E2A, and twist DNA binding specificities by different basic region-DNA conformations
102. Requirement of the mouse I-mfa gene for placental development and skeletal patterning
103. Serum-inducible factors binding to an activating transcription factor motif regulate transcription of the Id2A promoter during myogenic differentiation
104. Wiring diagrams: Regulatory circuits and the control of skeletal myogenesis
105. The role of positive and negative signals in somite patterning
106. MyoD is a sequence-specific DNA binding protein requiring a region of myc homology to bind to the muscle creatine kinase enhancer
107. Functional activity of myogenic HLH proteins requires hetero-oligomerization with E12/E47-like proteins in vivo
108. Regulatory mechanisms that coordinate skeletal muscle differentiation and cell cycle withdrawal
109. Cyclin dependent kinase 5, cdk5, is a positive regulator of myogenesis in mouse C2 cells
110. Myocyte-specific enhancer factor 2 and thyroid hormone receptor associate and synergistically activate the alpha-cardiac myosin heavy-chain gene
111. Down-regulation of transcription factors AP-1. Sp-1, NF-kappa B precedes myocyte differentiation
112. The basic helix-loop-helix transcription factor Mist1 functions as a transcriptional repressor of myoD
113. Mos activates myogenic differentiation by promoting heterodimerization of MyoD and E12 proteins
114. Fos and Jun repress transcriptional activation by myogenin and MyoD: The amino terminus of Jun can mediate repression
115. Cyclic AMP-dependent protein kinase inhibits the activity of myogenic helix-loop-helix proteins
116. Different members of the jun protooncogene family exhibit distinct patterns of expression in response to type beta transforming growth factor
117. FGF inactivates myogenic helix-loop-helix proteins through phosphorylation of a conserved protein kinase C site in their DNA-binding domains
118. Control of mouse cardiac morphogenesis and myogenesis by transcription factor MEF2C
119. Cell cycle-regulated expression of the muscle determination factor Myf5 in proliferating myoblasts
120. Mutation of Thr115 in MyoD positively regulates function in murine fibroblasts and human rhabdomyosarcoma cells
121. MyoR: A muscle-restricted basic helix-loop-helix transcription factor that antagonizes the actions of MyoD
122. Rb interacts with histone deacetylase to repress transcription
123. Id1 and Id3 are required for neurogenesis, angiogenesis and vascularization of tumour xenografts
124. Crystal structure of MyoD bHLH domain-DNA complex: Perspectives on DNA recognition and implications for transcriptional activation
125. TRAF2 expression in differentiated muscle
126. Twist is a potential oncogene that inhibits apoptosis
127. Retinoblastoma protein represses transcription by recruiting a histone deacetylase
128. Interdependence between muscle differentiation and cell-cycle control
129. Retinoblastoma antioncogene is involved in the inhibition of myogenesis by polyomavirus large T antigen
130. Ectopic Pax-3 activates MyoD and Myf-5 expression in embryonic mesoderm and neural tissue
131. Helix-loop-helix proteins: Regulators of transcription in eucaryotic organisms
132. Rhabdomyosarcoma - Working out the pathways
133. Upstream regions of the human cardiac actin gene that modulate its transcription in muscle cells: Presence of an evolutionarily conserved repeated motif
134. HDAC4 deacetylase associates with and represses the MEF2 transcription factor
135. Phosphorylation of the MADS-Box transcription factor MEF2C enhances its DNA binding activity
136. Cooperative activation of muscle gene expression by MEF2 and myogenic bHLH proteins
137. Combinatorial control of muscle development by basic helix-loop-helix and MADS-box transcription factors
138. In vivo footprinting of a muscle specific enhancer by ligation mediated PCR
139. Mechanisms of p53 loss in human sarcomas
140. Combinatorial signals from the neural tube, floor plate and notochord induce myogenic bHLH gene expression in the somite
141. Structure and function of helix-loop-helix proteins
142. Interactions between heterologous helix-loop-helix proteins generate complexes that bind specifically to a common DNA sequence
143. Regulation of vertebrate muscle differentiation by thyroid hormone: The role of the myoD gene family
144. Commitment, fusion and biochemical differentiation of a myogenic cell line in the absence of DNA synthesis
145. HLH forced dimers: Tethering MyoD to E47 generates a dominant positive myogenic factor insulated from negative regulation by Id
146. Id helix-loop-helix proteins in cell growth and differentiation
147. Skeletal muscle cells lacking the retinoblastoma protein display defects in muscle gene expression and accumulate in S and G2 phases of the cell cycle
148. pRb is required for MEF2-dependent gene expression as well as cell-cycle arrest during skeletal muscle differentiation
149. DNA binding specificity determinants in MADS-box transcription factors
150. An activated Notch suppresses neurogenesis and myogenesis but not gliogenesis in mammalian cells
151. Molecular pathways controlling heart development
152. The p38 signal transduction pathway: Activation and function
153. Knowing chops from chuck: Roasting myoD redundancy
154. Post-translational control of the MEF2A transcriptional regulatory protein
155. MEF2 protein expression, DNA binding specificity and complex composition, and transcriptional activity in muscle and non-muscle cells
156. Inactivation of MyoD-mediated expression of p21 in tumor cell lines
157. Regulation of G1 progression by E2A and Id helix-loop-helix proteins
158. The role of cyclin-dependent kinase 5 and a novel regulatory subunit in regulating muscle differentiation and patterning
159. The eye-specification proteins So and Eya form a complex and regulate multiple steps in Drosophila eye development
160. ZEB, a vertebrate homolog of Drosophila Zfh-1, is a negative regulator of muscle differentiation
161. Independent repressor domains in ZEB regulate muscle and T-cell differentiation
162. zfh-1, the Drosophila homologue of ZEB, is a transcriptional repressor that regulates somatic myogenesis
163. Regulation of the expression of cyclin-dependent kinase inhibitor p21 by E2A and Id proteins
164. Reactive oxygen intermediates mediate angiotensin II-induced c-Jun.c-Fos heterodimer DNA binding activity and proliferative hypertrophic responses in myogenic cells
165. MyoD prevents cyclinA/cdk2 containing E2F complexes formation in terminally differentiated myocytes
166. p300 is required for MyoD-dependent cell cycle arrest and muscle-specific gene transcription
167. Differential roles of p300 and PCAF acetyltransferases in muscle differentiation
168. Induction of terminal differentiation by constitutive activation of p38 MAP kinase in human rhabdomyosarcoma cell
169. Ectopic expression of cyclin D1 prevents activation of gene transcription by myogenic basic helix-loop-helix regulators
170. MyoD meets its maker
171. p57(Kip2) stabilizes the MyoD protein by inhibiting cyclin E-Cdk2 kinase activity in growing myoblasts
172. M-twist expression inhibits mouse embryonic stem cell-derived myogenic differentiation in vitro
173. MyoD or Myf-5 is required for the formation of skeletal muscle
174. Molecular mechanisms of myogenic coactivation by p300: Direct interaction with the activation domain of MyoD and with the MADS box of MEF2C
175. Acetylation of MyoD directed by PCAF is necessary for the execution of the muscle program
176. Muscle-specific expression of the cardiac alpha-actin gene requires MyoD1, CArG-box binding factor, and Sp1
177. Reversal of terminal differentiation mediated by p107 in Rb-/- muscle cells
178. Stable binding to E2F is not required for the retinoblastoma protein to activate transcription, promote differentiation, and suppress tumor cell growth
179. The NeuroD1/BETA2 sequences essential for insulin gene transcription colocalize with those necessary for neurogenesis and p300/CREB binding protein binding
180. D-type cyclins
181. Multiple change in E2F function and regulation occur upon muscle differentiation
182. Cyclin-mediated inhibition of muscle gene expression via a mechanism that is independent of pRB hyperphosphorylation
183. Inhibition of myogenic differentiation in proliferating myoblasts by cyclin D1-dependent kinase
184. Duplication of ATR inhibits MyoD, induces aneuploidy and eliminates radiation-induced G1 arrest
185. Phosphorylation of nuclear MyoD is required for its rapid degradation
186. Cell proliferation inhibited by MyoD1independently of myogenic differentiation
187. Growth and differentiation of C2 myogenic cells are dependent on serum response factor
188. MEF-2 function is modified by a novel co-repressor, MITR
189. Inhibition of myogenic bHLH and MEF2 transcription factors by the bHLH protein Twist
190. A subclass of bHLH proteins required for cardiac morphogenesis
191. Dorso-ventral and rostro-caudal sequential expression of M-twist in the postimplantation murine embryo
192. Mutation of the p53 gene in human soft tissue sarcomas: Association with abnormalities of the RB1 gene
193. Histone acetylation and transcriptional regulatory mechanisms
194. Jun inhibits myogenic differentiation
195. Constitutive expression of the Id1 gene impairs mouse B cell development
196. Establishing myogenic identity during somitogenesis
197. Redefining the genetic hierarchies controlling skeletal myogenesis: Pax-3 and Myf-5 act upstream of MyoD
198. Deficiency in rhabdomyosarcomas of a factor required for MyoD activity and myogenesis
199. MyoD1: A nuclear phosphoprotein requiring a Myc homology region to convert fibroblasts to myoblasts
200. Drosophila MEF2 is regulated by twist and is expressed in both the primordia and differentiated cells of the embryonic somatic, visceral and heart musculature
201. The inhibition of cultured myoblast differentiation by the simian virus 40 large T antigen occurs after myogenin expression and Rb up-regulation and is not exerted by transformation-competent cytoplasmic mutants
202. Rhabdomyosarcoma arising in transgenic mice harboring the beta-globin locus control region fused with simian virus 40 large T antigen gene
203. Positive autoregulation of the myogenic determination gene MyoD1
204. Sequence of the twist gene and nuclear localization of its protein in endomesodermal cells of early Drosophila embryos
205. Terminelly differentiated skeletal myotubes are not confined to GO but can enter G1 upon growth factor stimulation
206. Expression of E1A in terminally differentiated muscle cells reactivates the cell cycle and suppresses tissue-specific genes by separable mechanisms
207. Transcriptional activation: A complex puzzle with few easy pieces
208. The serum response element
209. Induced alpha helix in the VP16 activation domain upon binding to a human TAF
210. Serum response factor p67SRF is expressed and required during myogenic differentiation of both mouse C2 and rat L6 muscle cell lines
211. The ubiquitin system
212. Coordinate regulation of cell cycle and apoptosis during myogenesis
213. Cell cycle exit upon myogenic differentiation
214. Cellular responses to DNA damage
215. Rb functions to inhibit apoptosis during myocyte differentiation
216. The myoD gene family: Nodal point during specification of the muscle cell lineage
217. Muscle-specific transcriptional activation by MyoD
218. Tissue-specific gene activation by MyoD: Determination of specificity by cis-acting repression elements
219. Activated notch inhibits myogenic activity of the MADS-Box transcription factor myocyte enhancer factor 2C
220. cAMP-dependent protein kinase represses myogenic differentiation and the activity of the muscle-specific helix-loop-helix transcription factors Myf-5 and MyoD
221. Two putative protein kinase CK2 phosphorylation sites are important for Myf-5 activity
222. The M-twist gene of Mus is expressed in subsets of mesodermal cells and is closely related to the Xenopus X-twi and the Drosophila twist genes
223. p38 and extracellular signal-regulated kinases regulate the myogenic program at multiple steps
224. Regulation of a muscle-specific transgene by retinoic acid
225. Interaction of myocyte enhancer factor 2 (MEF2) with a mitogen-activated protein kinase, ERK5/BMK1
226. Targeting of p38 mitogen-activated protein kinases to MEF2 transcription factors
227. Human p300 protein is a coactivator for the transcription factor MyoD
228. Skeletel muscle determination and differentiation: Stow of a core regulatory network and its context
229. pRb controls proliferation, differentiation, and death of skeletal muscle and other lineages during embryogenesis
230. p38 Mitogen-activated protein kinase pathway promotes skeletal muscle differentiation. Participation of the Mef2c transcription factor
231. Coupling of the cell cycle and myogenesis through the cyclin D1-dependent interaction of MyoD with cdk4
232. Direct inhibition of G(1) cdk kinase activity by MyoD promotes myoblast cell cycle withdrawal and terminal differentiation
233. Regulation of the MEF2 family of transcription factors by p38
234. Dimerization through the helix-loop-helix motif enhances phosphorylation of the transcription activation domains of myogenin